Vliet, M. van

patient cyp 2c tumor study sarcoma allele tamoxifen genotype effect t 1wi swine plasma cyp 2d cancer tissue adenosine treatment channel breast concentration level variant polymorphism cyp 2c allele heart cytochrome exercise group voriconazole control therapy katp channels t 2wi contrast administration contrast imi dose requirement netherland enzyme imaging liposarcoma epithelioid carrier imi dose cyp 2c genotype physiol liver requirement myxoid 8- pt cohort metabolizer complication metabolism imipramine pleomorphic mi swine administration ratio cell sarcoma breast cancer patients rhabdomyosarcoma frequency synovial sarcoma state activity involvement number genotyping feature glibenclamide anticoagulant erasmus mc status cyp 3a expressers adenosine receptor blockade tissue sarcomas disease kruskal –wallis test blood fl ow acenocoumarol